About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.